Click here to attend.

The meeting will take place via Zoom. 

Speaker:
Edgar Lerma, MD
Clinical Professor of Medicine
University of Illinois at Chicago College of Medicine

At the conclusion of this activity the participants should be able to:

• Discuss Epidemiology of HCC including the review of progression over the years and discuss risk factors that affect incident and survival
• Review surveillance recommendations for HCC in adults
• Review imaging modalities and diagnostic features of HCC
• Discuss treatment approaches for HCC: curative versus non curative therapy

Disclosure: 

The speaker, Dr. Edgar Lerma has disclosed that he is a Steering Committee Member and Speaker for Bayer Pharma and a Physician Advisory Board Member for Otsuka, Vifor and Bayer Pharma.  The planners have indicated that there are no relevant financial relationships with any ineligible companies to disclose.   Conflict of interests have been identified and mitigated prior to activity.   

Accreditation Statement: Advocate Aurora Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement: Advocate Aurora Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Part II: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation information will be shared with the applicable Board through the Accreditation Council for Continuing Medical Education (ACCME) Program and Activity Reporting System (PARS).